Meanwhile, lipid accumulation, insulin resistant, oxidative stress and inflammation response have been widely suggested to play a pivotal role in the transition from steatosis to NASH [21,22]. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.